Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1705339 CAUSEWAY BAY, K3
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$286,388
-$1,623 QoQ
Shares Held
35,754
-0.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 208 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. SPRY ranks #168 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 150,692 $74,853,236
2 REGN
Regeneron Pharmaceuticals, Inc.
 59,595 $37,159,864
3 ALNY
Alnylam Pharmaceuticals, Inc.
 63,265 $19,044,662
4 RPRX
Royalty Pharma plc
 259,390 $14,543,997
5 TWST
Twist Bioscience Corp
 100,108 $10,299,110
6 INCY
Incyte Corp
 83,084 $9,418,401
7 PRAX
Praxis Precision Medicines, Inc.
 27,185 $9,101,265
8 MRNA
Moderna, Inc.
 106,564 $7,462,676

All Filings in SPRY

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $286,388 35,754
2026-03-31 $288,011 35,867
2025-12-31 $397,264 34,100
2025-09-30 $338,302 33,662
2025-06-30 $593,195 33,994
2025-03-31 $412,120 32,760
2024-12-31 $354,057 33,560
2024-09-30 $438,378 30,233
2024-06-30 $138,100 16,228